These compounds may interact with:
cGMP-specific 3',5'-cyclic phosphodiesterase
Potentially involved in: carcinoma; impotence; premature ejaculation; priapism; hypertension; peyronie's disease; anterior ischemic optic neuropathy; dyspepsia; hypogonadism; diabetes mellitus; heart disease; coronary artery disease; hypoactive sexual desire disorder; prostatic hypertrophy; stuttering; neoplasm metastasis; atypical teratoid / rhabdoid tumor; breast cancer; breast carcinoma; colon cancer
Disease data sourced from Pharos.